Top

Researchers look for ways to prevent chemotherapy-induced cognitive impairment

October 3, 2017

Category:

Of the 14 million cancer survivors in the United States, a significant number experience a serious side effect called chemotherapy-induced cognitive impairment (CICI). While easily recognized, little is known about the etiology of this condition, also known informally as “chemo brain.” CICI can significantly reduce patients’ quality of life with serious, even devastating, symptoms such as memory lapses, difficulty concentrating, negative impacts on multitasking, confusion, and fatigue.

Three University of Kentucky Markey Cancer Center researchers are tackling this problem head-on, serving as principal investigators on a new $2.3 million grant awarded by the National Institutes of Health:

Read More on The Medical News